Back to calendar
Prelude Therapeutics Incorporated (PRLD) Earnings
PRLD reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.11
Actual EPS: $-0.14
Company overview
Market Cap$446.9M
SectorHealth Technology
IndustryBiotechnology